Welcome to CDC stacks | Increased Amoxicillin–Clavulanic Acid Resistance in Escherichia coli Blood Isolates, Spain - 16994 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Increased Amoxicillin–Clavulanic Acid Resistance in Escherichia coli Blood Isolates, Spain
  • Published Date:
    Aug 2008
  • Source:
    Emerg Infect Dis. 14(8):1259-1262.
Filetype[PDF-383.63 KB]


Details:
No Related Documents.
You May Also Like:
  1. Human Infections with Non-O157 Shiga Toxin–producing Escherichia coli, Switzerland, 2000–2009
    Personal Author:
    Käppeli, Ursula; Hächler, Herbert; Giezendanner, Nicole; Beutin, Lothar; Stephan, Roger;
    Published:
    Feb 2011
    Source:
    Emerg Infect Dis. 17(2):180-185.
    Description:
    We characterized 97 non-O157 Shiga toxin (stx)-producing Escherichia coli strains isolated from human patients during 2000-2009 from the national reference laboratory in Switzerland. These strains belonged to 40 O:H serotypes; 4 serotypes (O26:H11/H-...
    File Type:
    Filetype[PDF - 160.93 KB]
  2. Integrating Escherichia coli Antimicrobial Susceptibility Data from Multiple Surveillance Programs
    Personal Author:
    Stelling, John M.; Travers, Karin; Jones, Ronald N.; Turner, Philip J.; O'Brien, Thomas F.; Levy, Stuart B.;
    Published:
    Jun 2005
    Source:
    Emerg Infect Dis. 11(6):873-882.
    Description:
    Collaboration between networks presents opportunities to increase analytical power and cross-validate findings. Multivariate analyses of 2 large, international datasets (MYSTIC and SENTRY) from the Global Advisory on Antibiotic Resistance Data progra...
    File Type:
    Filetype[PDF - 609.03 KB]
  3. National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS) : human isolates final report, 2006
    Corporate Author:
    National Antimicrobial Resistance Monitoring System--Enteric Bacteria (U.S.); National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Foodborne, Waterborne, and Environmental Diseases.;
    Published:
    7/9/09
    Description:
    The National Antimicrobial Resistance Monitoring System (NARMS) for Enteric Bacteria is a collaboration among the Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA-CVM), and U.S. Department of Agriculture (USDA). The...
    File Type:
    Filetype[PDF - 2.30 MB]
  4. Antimicrobial Drug Resistance in Escherichia coli from Humans and Food Animals, United States, 1950–2002
    Personal Author:
    Tadesse, Daniel A.; Zhao, Shaohua; Tong, Emily; Ayers, Sherry; Singh, Aparna; Bartholomew, Mary J.; McDermott, Patrick F.;
    Published:
    May 2012
    Source:
    Emerg Infect Dis. 18(5):741-749.
    Description:
    We conducted a retrospective study of Escherichia coli isolates recovered from human and food animal samples during 1950-2002 to assess historical changes in antimicrobial drug resistance. A total of 1,729 E. coli isolates (983 from humans, 323 from ...
    File Type:
    Filetype[PDF - 483.77 KB]
  5. National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS) : human isolates final report, 2005
    Corporate Author:
    National Antimicrobial Resistance Monitoring System--Enteric Bacteria (U.S.); National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Foodborne, Waterborne, and Environmental Diseases.;
    Published:
    7/1/09
    Description:
    The National Antimicrobial Resistance Monitoring System (NARMS) for Enteric Bacteria is a collaboration among the Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), and U.S. Department of Agriculture (USDA). The pri...
    File Type:
    Filetype[PDF - 1.19 MB]